Etorphine elicits unique inhibitory-agonist and excitatory-antagonist actions at opioid receptors on sensory neurons: new rationale for improved clinical analgesia and treatment of opiate addiction.
Crain
S M
SM
Department of Neuroscience, Yeshiva University, Bronx, NY 10461, USA.
Shen
K F
KF
D000818:Animals; D005048:Etorphine / Q000494:pharmacology* / Q000627:therapeutic use; D018691:Excitatory Amino Acid Antagonists / Q000494:pharmacology* / Q000627:therapeutic use; D009292:Narcotic Antagonists; D009475:Neurons, Afferent / Q000187:drug effects* / Q000378:metabolism; D009293:Opioid-Related Disorders / Q000188:drug therapy*; D010146:Pain / Q000188:drug therapy*; D011957:Receptors, Opioid / Q000819:agonists*
D018691:Excitatory Amino Acid Antagonists; D009292:Narcotic Antagonists; D011957:Receptors, Opioid; D005048:Etorphine